{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:43Z","timestamp":1758588163749,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003790","name":"Hiroshima University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.transproceed.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T01:27:22Z","timestamp":1573694842000},"page":"600-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report"],"prefix":"10.1016","volume":"52","author":[{"given":"Hiroaki","family":"Yamane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Nagoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhmet","family":"Seidakhmetov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doskali","family":"Marlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.06.006_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.06.006_bib2","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.06.006_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009","volume":"65","author":"Butler","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.06.006_bib4","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2019.06.006_bib5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bpobgyn.2014.08.007","article-title":"Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors","volume":"28","author":"Piselli","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ajcp\/aqx133","article-title":"Myeloid neoplasms following solid organ transplantation: clinicopathologic studies of 23 cases","volume":"149","author":"Wu","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib7","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/leu.2014.132","article-title":"Risk of myeloid neoplasms after solid organ transplantation","volume":"28","author":"Morton","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.transproceed.2019.06.006_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.06.006_bib9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","article-title":"Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Goldman","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.06.006_bib10","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/ndt\/gfm052","article-title":"Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukemia after renal transplantation","volume":"22","author":"Thierry","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.06.006_bib11","first-page":"388","article-title":"Successful treatment of chronic myelogenic leukemia (CML) with imatinib after renal transplantation","volume":"17","author":"Eishei Oskuei","year":"2014","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.transproceed.2019.06.006_bib12","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-year study results of DASISION: the dasatinib versus imatinib study in treatment-na\u00efve chronic myeloid leukemia patients trial","volume":"34","author":"Cortes","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12185-017-2208-2","article-title":"Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report","volume":"105","author":"Nakamae","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/dmd.107.018267","article-title":"Metabolism and disposition of dasatinib after oral administration to humans","volume":"36","author":"Christopher","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.transproceed.2019.06.006_bib15","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1182\/blood-2010-07-294330","article-title":"Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib","volume":"117","author":"Haouala","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2019.06.006_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.12885","article-title":"Elevated incidence of chronic myeloid leukemia in immunosuppressed solid organ transplant recipients","volume":"166","author":"Dhanarajan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0301-472X(01)00633-6","article-title":"Novel\u00a0therapies for chronic myelogenous leukemia","volume":"29","author":"Jahagirdar","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.06.006_bib19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: mechanisms of resistance to imatinib in chronic myeloid leukemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.2008.19.8853","article-title":"Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR\/ABL mutants","volume":"27","author":"Redaelli","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-2-10","article-title":"New dosing schedules of dasatinib for CML and adverse event management","volume":"2","author":"Wong","year":"2009","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clml.2015.12.003","article-title":"Clinical safety and efficacy of nilotinib or dasatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia and pre-existing liver and\/or renal dysfunction","volume":"16","author":"Sasaki","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.transproceed.2019.06.006_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.leukres.2009.07.009","article-title":"Renal failure associated with tyrosine kinase inhibitors--case report and review of the literature","volume":"34","author":"Gafter-Gvili","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.transproceed.2019.06.006_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood-2009-12-256800","article-title":"Mono\/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy","volume":"116","author":"Kreutzman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2019.06.006_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1081\/IMM-120038079","article-title":"Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation","volume":"33","author":"Tanaka","year":"2004","journal-title":"Immunol Invest"},{"key":"10.1016\/j.transproceed.2019.06.006_bib26","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.transproceed.2011.05.039","article-title":"Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report","volume":"43","author":"Tanimine","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.06.006_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.humimm.2016.04.013","article-title":"Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation","volume":"77","author":"Morimoto","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2019.06.006_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.humimm.2017.03.006","article-title":"Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients","volume":"78","author":"Das","year":"2017","journal-title":"Hum Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519308747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519308747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:33:23Z","timestamp":1758576803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519308747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0041134519308747"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.06.006","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}